1 in 4 Australian men are diagnosed
One in four Australian men will be diagnosed with prostate cancer at some stage in their life, but for a disease that’s so common there’s much we don’t know about it.
Because there’s so much we still don’t know, many Australian men are being over-treated, receiving invasive, sometimes life-altering treatments that may not be necessary.
Ground-breaking research at the Garvan Institute is transforming the way we look at prostate cancer, giving us a better understanding of this devastating disease.
The problem: potential over-treatment of prostate cancer
While it’s very common, we are still learning what causes it and more importantly, how best to treat it.
For some, that treatment will lead to the distress of erectile dysfunction, for others, incontinence. Many will suffer the emotional toll caused by simply knowing the cancer is there – an enemy within they cannot fight.
Psychologically, it’s a very hard cancer to deal with.
The solution: using genetic insights to determine the correct treatment
Professor Vanessa Hayes’ team is working to put prostate cancer in different buckets, so clinicians can adopt the best approach to help patients. All prostate cancer diagnoses are not created equal – and a key challenge is to treat aggressive cancers decisively, while avoiding potentially damaging over-treatment of less aggressive disease.
Ultimately, we hope to be able to help clinicians give the right treatment to the right person at the right time.